Sihuan Pharmaceutical Ownership
| SHPHF Stock | USD 0.10 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Sihuan |
Sihuan Pink Sheet Ownership Analysis
About 55.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.81. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sihuan Pharmaceutical last dividend was issued on the 4th of October 2022. The entity had 2:1 split on the 5th of June 2014. Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the Peoples Republic of China. The company was founded in 2001 and is based in Wanchai, Hong Kong. Sihuan Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3896 people.The quote for Sihuan Pharmaceutical Holdings is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Sihuan Pharmaceutical Holdings contact Weicheng Guo at 852 3628 3911 or learn more at https://www.sihuanpharm.com.Currently Active Assets on Macroaxis
| VALE | Vale SA ADR | |
| EGY | Vaalco Energy | |
| CMCSA | Comcast Corp | |
| BTE | Baytex Energy Corp | |
| SOXS | Direxion Daily Semiconductor |
Other Information on Investing in Sihuan Pink Sheet
Sihuan Pharmaceutical financial ratios help investors to determine whether Sihuan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sihuan with respect to the benefits of owning Sihuan Pharmaceutical security.